James Z Huang's most recent trade in Alaunos Therapeutics Inc was a trade of 100,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
Windtree Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 2,224,616 | 2,224,616 | - | - | Warrants (right to purchase) | |
Windtree Therapeutics Inc | James Z. Huang | Director | 22 Feb 2023 | 1,112,308 | 3,449,161 (10%) | 3% | 0.1 | 156,947 | Common Stock | |
Windtree Therapeutics Inc | James Z. Huang | Director | 22 Feb 2023 | 1,112,308 | 0 | - | - | Warrants (right to purchase) | ||
Windtree Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 1,112,308 | 1,112,308 | - | - | Warrants (right to purchase) | |
Windtree Therapeutics Inc | James Z. Huang | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 498,008 | 0 | - | - | Warrants (right to purchase) | |
Windtree Therapeutics Inc | James Z. Huang | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 275,938 | 0 | - | - | Warrants (right to purchase) | |
Windtree Therapeutics Inc | James Z. Huang | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 275,862 | 0 | - | - | Warrants (right to purchase) | |
Windtree Therapeutics Inc | James Z. Huang | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 62,500 | 0 | - | - | Warrants (right to purchase) | |
CASI Pharmaceuticals Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 4.28 per share. | 06 Sep 2022 | 33,300 | 371,517 (0%) | 0% | 4.3 | 142,627 | Common Stock |
CASI Pharmaceuticals Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 3.89 per share. | 06 Sep 2022 | 19,162 | 335,106 (0%) | 0% | 3.9 | 74,601 | Common Stock |
CASI Pharmaceuticals Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 06 Sep 2022 | 3,111 | 338,217 (0%) | 0% | 4.0 | 12,433 | Common Stock |
CASI Pharmaceuticals Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 3.27 per share. | 19 Aug 2022 | 171,116 | 171,116 (0%) | 0% | 3.3 | 559,447 | Common Stock |
CASI Pharmaceuticals Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 19 Aug 2022 | 40,000 | 234,221 (0%) | 0% | 3.5 | 139,992 | Common Stock |
CASI Pharmaceuticals Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 3.46 per share. | 19 Aug 2022 | 23,105 | 194,221 (0%) | 0% | 3.5 | 80,038 | Common Stock |
Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 80,000 | 188,333 (0%) | 0% | 0 | Common Stock | |
Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 80,000 | 188,333 (0%) | 0% | 0 | Common Stock | |
Windtree Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
Windtree Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 5,000 | 296,281 (0%) | 0% | 0 | Common Stock | |
CASI Pharmaceuticals Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 397,419 | 397,419 | - | - | Stock Option (Right to Buy) | |
Windtree Therapeutics Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 19 Oct 2021 | 50,000 | 291,281 (0%) | 0% | 1.9 | 95,135 | Common Stock |
Alaunos Therapeutics Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 1.71 per share. | 01 Sep 2021 | 100,000 | 108,333 (0%) | 0% | 1.7 | 171,000 | Common Stock |
Windtree Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Windtree Therapeutics Inc | James Z. Huang | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.36 per share. | 31 Mar 2021 | 150,000 | 171,000 (0%) | 0% | 2.4 | 354,000 | Common Stock |
Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 8,333 | 8,333 (0%) | 0% | 0 | Common Stock | |
Windtree Therapeutics Inc | James Z. Huang | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Windtree Therapeutics Inc | James Z. Huang | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.67 per share. | 23 Oct 2020 | 1,000 | 21,000 (0%) | 0% | 6.7 | 6,666 | Common Stock |
Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2020 | 119,178 | 119,178 | - | - | Stock Option (right to buy) | |
CASI Pharmaceuticals Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 70,400 | 70,400 | - | - | Stock Option (Right to Buy) | |
Windtree Therapeutics Inc | James Z. Huang | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.32 per share. | 03 Jun 2020 | 12,000 | 20,000 (0%) | 0% | 7.3 | 87,868 | Common Stock |
Windtree Therapeutics Inc | James Z. Huang | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.25 per share. | 22 May 2020 | 275,862 | 2,336,853 (7%) | 0% | 7.3 | 2,000,000 | Common Stock |
Windtree Therapeutics Inc | James Z. Huang | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 May 2020 | 275,862 | 275,862 | - | - | Common Stock Warrants |